Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR0FK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,074
Award facts
- Contract value 100% obligated
- $58,074.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $58,074.01 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections on December 22, 2025, with completion targeted for December 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive portfolio of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract awards with DLA consistently involve delivery orders for brand-name and generic pharmaceuticals across multiple therapeutic domains, ranging from diabetes and neurological medications to specialty medical supplies. This particular delivery order for Dupixent, a biologic treatment for inflammatory conditions, exemplifies AmerisourceBergen's role in ensuring the Department of Defense and military healthcare systems have access to specialized pharmaceutical products through competitive federal procurement.
Quick answers
Who was awarded contract SPE2DR26FR0FK?
SPE2DR26FR0FK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FR0FK worth?
The government has obligated $58,074 on SPE2DR26FR0FK.
Is contract SPE2DR26FR0FK an order under another contract?
Yes. SPE2DR26FR0FK is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0FK competed?
The extent of competition for SPE2DR26FR0FK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award